Monthly Archives: March 2011

Recurrence Score Factors Into Physician Treatment Decisions More Often When Breast Cancer Tumors Are Smaller

A recent PHAR, LLC study evaluated treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer. Specifically, investigators sought to determine the effect of the 21-gene recurrence score (RS) assay results on physician decision making for such patients. The findings show that the RS result was used in determining treatment more often when patients… read more